Skip to main content

Clinical Trials

Search among the clinical trials we have open at the Vall d'Hebron Research Institute.

Phase Title Sort descending Service Recruitment
Phase III A Two-Part Multicenter, Double-Blind, Randomized Placebo-Controlled… Unclassified Yes
Phase IV Ácido ursOdesoxicólico vS placebO para la PrevenciÓn de… Digestive Yes
Phase III AFFIRM: A Randomized, double-blind, placebo-controlled, study to evaluate the… Hepatology No
Phase II An adaptive, Phase 2, double-blind, randomized, placebo-controlled,… Neurology Yes
Phase II An Exploratory, Multicenter, Randomized, double-blind, placebo-… Psychiatry Yes
Phase II An Integrated Phase I/II, Multicentre, Double-Blind, Randomised… Rehabilitation Yes
Phase III An interventional efficacy and safety phase 3, double-blind, 2-arm… RTA ICU Yes
Phase III AN INTERVENTIONAL EFFICACY AND SAFETY, PHASE 3,DOUBLE-BLIND, 2-… Infectious No
Phase II An Open Label Clinical Trial to Evaluate the Efficacy and Safety of PRAX-628… Neurology Yes
Phase III An open label complex clinical trial in newly diagnosed pediatric de… Pediatric Oncohematology Yes
Phase III An Open-Label Extension Study of EryDex in Patients with Ataxia… General Pediatrics and Specialties Yes
Phase III “An Open-Label Extension Study to Assess the Long-Term Safety of Eplontersen (… Cardiology Yes
Phase III An Open-Label Extension to Investigate the Long-Term Safety, Tolerability, and… General Pediatrics and Specialties Yes
Phase III An open-label extension trial of the long-term safety and efficacy ofBl… Pneumology Yes
Phase II AN OPEN-LABEL, LONG TERM SAFETY AND EFFICACY STUDY OF DONIDALORSEN IN THE… Internal Medicine Yes
Phase I An open-label, multiple dose, multicenter study to evaluate the… Rheumatology Yes
Phase II An Open-Label, Single-Arm Study to Evaluate the Efficacy, Pharmacokinetics, and… General Pediatrics and Specialties No
Phase III Antibióticos alternativos orales y?neuropenetrantes?para pacientes con sífilis Infectious No
Phase IV ASSURE : Estudio abierto a largo plazo para evaluar la… Hepatology Yes
Phase I Bayer 20810 - Estudio en fase I/II del inhibidor de la… Pediatric Oncohematology Yes
Phase IV BHV3000-406: Ensayo en fase IV, aleatorizado, doble ciego,… Neurology Yes
Phase IV BHV3000-407: Estudio en fase IV, aleatorizado, doble ciego,… Neurology Yes
Phase IV Bictegravir / FTC / TAF (Bictarvy®) combinado con darunavir /… Infectious Yes
Phase IV Clinical Efficacy of oral FosfomycinTrometamol and Cefixime in the… Infectious Yes